Freshpet, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 09, 2017 21:05 pm UTC| Business
SECAUCUS, N.J., March 09, 2017 -- Freshpet, Inc. (“Freshpet” or the “Company”) (NASDAQ:FRPT) today reported financial results for its fourth quarter and full year ended December 31, 2016. Fourth Quarter 2016...
Bingo Nation Announces Rollout Plans
Mar 09, 2017 21:05 pm UTC| Business
LAS VEGAS, March 09, 2017 -- Bingo Nation Inc. (OTC:BLTO.QB) (the “Company”) announced today the next step in the company’s plans to accelerate rollout of its technology by awarding distribution rights to strategic...
Inventure Foods to Report Fourth Quarter and Fiscal 2016 Financial Results on March 30, 2017
Mar 09, 2017 21:05 pm UTC| Business
PHOENIX, March 09, 2017 -- Inventure Foods, Inc. (Nasdaq:SNAK), a leading specialty food marketer and manufacturer, today announced that it will release its financial results for the fourth quarter and fiscal year ended...
Hallmark Financial Services, Inc. Announces Fourth Quarter and Fiscal 2016 Results
Mar 09, 2017 21:05 pm UTC| Business
FORT WORTH, Texas, March 09, 2017 -- Hallmark Financial Services, Inc. (NASDAQ:HALL) today announced results for its fourth quarter and fiscal year ended December 31, 2016, including the following highlights: Fiscal...
Tyson Foods to Present at CAGE Conference
Mar 09, 2017 21:05 pm UTC| Business
SPRINGDALE, Ark., March 09, 2017 -- Tyson Foods, Inc. (NYSE:TSN) will webcast its presentation at the Consumer Analyst Group of Europe (CAGE) conference in London on Tuesday, March 21, at 12:15 p.m. EDT. Representing...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 09, 2017 21:05 pm UTC| Business
TUSTIN, Calif., March 09, 2017 -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E...
Mar 09, 2017 21:05 pm UTC| Business
Investor webcast planned for April 2, 2017 at 9:00 AM EDT to discuss Phase 1b study results Prothena and Roche to co-host symposium on alpha-synuclein pathology and non-motor manifestations in Parkinson’s disease on March...